Skip to main content
PepStack
Blutwerte · Marker

Progesteron

Progesterone · P4

Hormone — ReproduktionsachseZeitabhängig
Einheit:
ng/mL
Abbreviation
P4

Progesterone test quantifies the level of progesterone hormone in the blood.

Reference Ranges

Reference
1.5–20ng/mL
1.5
20
LowNormalHigh
Reference
Unit · ng/mL

Ranges vary significantly with menstrual cycle phase and pregnancy status.

Overview

Übersicht

Progesterone (P4) is a steroid hormone primarily involved in the menstrual cycle, pregnancy, and embryogenesis. It is synthesized in the ovaries, adrenal glands, and placenta, playing a crucial role in preparing the endometrium for implantation and maintaining pregnancy. Researchers have observed that progesterone modulates estrogen receptor activity, particularly in breast cancer, where it serves as a prognostic biomarker. Clinically, progesterone levels are significant in assessing reproductive health, with variations indicating conditions such as luteal phase defects, ovarian cysts, or adrenal hyperplasia. In neonatal health, progesterone withdrawal can lead to neonatal menstruation, a phenomenon linked to fetal distress. For athletes and biohackers, progesterone's influence on mood, energy, and muscle recovery is of interest, though its direct impact on performance is less clear. Researchers found that time-of-day and menstrual cycle phase can affect progesterone levels, necessitating standardized testing conditions. Confounders include hormonal contraceptives and certain medications that can alter progesterone metabolism.

Klinische Bedeutung

Elevated progesterone levels may indicate pregnancy, ovarian cysts, or adrenal hyperplasia. Reduced levels can suggest luteal phase defects, amenorrhea, or potential miscarriage.

Dynamics

Trend Interpretation

Rising Values

Progressively rising progesterone levels may indicate pregnancy or ovarian cysts. Re-test if levels are unexpectedly high.

Falling Values

Falling levels can suggest luteal phase defects or risk of miscarriage.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Pregnancy
  • Ovarian cysts
  • Adrenal hyperplasia
  • Hormone replacement therapy
  • Certain medications
Cause

Low Levels

  • Luteal phase defect
  • Amenorrhea
  • Miscarriage risk
  • Hypogonadism
  • Chronic stress
Protocol

How to Optimize

Lever

Lifestyle

  • Manage stress levels
  • Regular exercise
  • Adequate sleep
Lever

Nutrition

  • Consume healthy fats
  • Increase fiber intake
Lever

Supplementation

  • Chasteberry
  • Vitamin B6
  • Zinc

Note:

Consult a healthcare provider before making significant lifestyle changes.

Testing Guidelines

✓Fasting Not Required
🕐Time-Sensitive

Test during the luteal phase for females; levels fluctuate throughout the day.

Testing Frequency

Annually for women with irregular cycles or reproductive issues.

Interfering Factors

  • Hormonal contraceptives
  • Certain medications
  • Menstrual cycle phase

Related Peptides & Hormones

Estrogen

Correlated with

hormone

Open Research Questions

Current research suggests that the clinical significance of progesterone responses in neonatal menstruation and their potential link to adolescent disorders remains understudied. Researchers have not yet established optimal reference ranges for progesterone receptor expression in various breast cancer subtypes, particularly regarding PGRMC1's role. Additionally, unanswered clinical questions include the mechanisms by which PGRMC1 regulates cell viability in ovarian cancer and the implications of progesterone signaling in fetal distress during neonatal menstruation.

52 Research Publications

1,302

Total Citations

15

Human/RCT

2.3

Avg. Influence

2025

Latest

Sort
Filter
#01

Neuroprotection by Estrogen and Progesterone in Traumatic Brain Injury and Spinal Cord Injury.

ReviewInfluence5.0
197
This review highlighted the neuroprotective effects of estrogen and progesterone following traumatic brain injury and spinal cord injury. Researchers found that these hormones are associated with improved neurological outcomes and reduced neuronal apoptosis.
View on PubMed
#02

Progesterone withdrawal: key to parturition.

ReviewInfluence6.0
191
This review focused on the role of progesterone withdrawal in initiating labor. Researchers found that unlike other mammals, humans do not exhibit a significant drop in progesterone levels before labor. The study discusses the implications of this difference for understanding human parturition.
View on PubMed
#03

Estrogen and progesterone receptors in breast cancer.

ReviewInfluence2.0
127
This study reviewed the importance of estrogen and progesterone receptors in breast cancer management. Researchers found that hormone receptor status is a significant predictive and prognostic biomarker, influencing treatment decisions and patient outcomes.
View on PubMed
#04

The Role of Progesterone Receptors in Breast Cancer.

ReviewInfluence1.0
116
This study examined the role of progesterone receptors in breast cancer. Researchers found that high expression of progesterone receptors is associated with better prognosis in hormone-positive breast cancer. The study also highlighted the importance of progesterone receptors in the context of endocrine therapy.
View on PubMed
#05

The eutopic endometrium in endometriosis: are the changes of clinical significance?

Review
115
Researchers found that the eutopic endometrium in women with endometriosis exhibits significant changes compared to healthy controls. The study highlighted the concept of 'progesterone resistance' as a key factor in the pathogenesis of endometriosis.
View on PubMed
#06

Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma.

HumanInfluence2.0
77
Researchers explored serum proteomic biomarkers for the early diagnosis of hepatocellular carcinoma (HCC) and identified a panel that effectively distinguishes HCC from liver cirrhosis and healthy individuals. The study demonstrated the potential of proteomics-driven biomarker discovery to improve early diagnosis of HCC.
View on PubMed
#07

Progesterone signaling mediated through progesterone receptor membrane component-1 in ovarian cells with special emphasis on ovarian cancer.

AnimalInfluence2.0
64
Researchers found that PGRMC1 is crucial for the survival of ovarian cells and is expressed in ovarian tumors. The study demonstrated that depletion of PGRMC1 in ovarian cancer cells resulted in smaller tumors and reduced tumor formation in mice.
View on PubMed
#08

90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future.

Review
48
This review traced the history and significance of progesterone receptors in breast cancer. Researchers found that progesterone receptors are crucial for predicting treatment responses and have complex roles in tumor biology. The study discusses emerging research on progesterone's dual roles in cancer progression.
View on PubMed
#09

PGRMC1: a new biomarker for the estrogen receptor in breast cancer.

HumanInfluence1.0
41
This study examined the expression of PGRMC1 as a biomarker in breast cancer. Researchers found that PGRMC1 levels are elevated in ER-negative tumors and are mutually exclusive with estrogen receptor expression, suggesting its potential role in tumor hypoxia.
View on PubMed
#10

Ovulation timing. Concepts and controversies.

HumanInfluence2.0
30
Researchers highlighted the advancements in ovulation timing through the use of progesterone and LH assays. The study noted that these assays enable high accuracy in predicting ovulation timing in veterinary practice.
View on PubMed

Clinical Trials (4)

4

Total Trials

564

Total Enrolled

Natural Progesterone for the Treatment of Recurrent Glioblastoma

NCT05091866Early Phase 1TERMINATED
Sponsor

Emory University

Enrollment

4

Started

2022

Primary outcome

Natural progesterone blood levels

GliosarcomaRecurrent Glioblastoma

Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy

NCT05586724Phase 3RECRUITING
Sponsor

Angelica Lindén Hirschberg

Enrollment

520

Started

2022

Primary outcome

Mammographic breast density

Menopausal Symptoms

Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals

NCT02400021Phase 2UNKNOWN
Sponsor

Mount Sinai Hospital, Canada

Enrollment

40

Started

2015

Primary outcome

Total enrollment / eligible population per year

HIV-1 Infection

Vaginal Progesterone as a Treatment for Women Active Preterm Labor

NCT01206998WITHDRAWN
Sponsor

University of Rochester

Enrollment

0

Started

2010

Primary outcome

Latency to delivery

Labor, Premature

Publication Trend

Research publications about Progesteron over time

10total
1
'85
1
'08
1
'12
1
'16
1
'18
1
'20
4
'22

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer